Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Human papillomavirus vaccination: the policy debate over the prevention of cervical cancer--a commentary.

Hoops KE, Twiggs LB.

J Low Genit Tract Dis. 2008 Jul;12(3):181-4. doi: 10.1097/LGT.0b013e31815f98b5.

PMID:
18596458
2.

Human papillomavirus vaccine: the beginning of the end for cervical cancer.

Bornstein J.

Isr Med Assoc J. 2007 Mar;9(3):156-8. Review.

3.

Human papillomavirus, cervical cancer, and the vaccines.

Tovar JM, Bazaldua OV, Vargas L, Reile E.

Postgrad Med. 2008 Jul;120(2):79-84. doi: 10.3810/pgm.2008.07.1794. Review.

PMID:
18654072
4.

Indications and efficacy of the human papillomavirus vaccine.

Hakim AA, Lin PS, Wilczynski S, Nguyen K, Lynes B, Wakabayashi MT.

Curr Treat Options Oncol. 2007 Dec;8(6):393-401. doi: 10.1007/s11864-007-0050-0. Review.

PMID:
18172770
5.

Lessons from the failure of human papillomavirus vaccine state requirements.

Schwartz JL, Caplan AL, Faden RR, Sugarman J.

Clin Pharmacol Ther. 2007 Dec;82(6):760-3. Epub 2007 Oct 31.

PMID:
17971822
7.

American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.

Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, Goldie SJ, Harper DM, Kinney W, Moscicki AB, Noller KL, Wheeler CM, Ades T, Andrews KS, Doroshenk MK, Kahn KG, Schmidt C, Shafey O, Smith RA, Partridge EE; Gynecologic Cancer Advisory Group, Garcia F.

CA Cancer J Clin. 2007 Jan-Feb;57(1):7-28. Review.

PMID:
17237032
8.

Human papillomavirus vaccines: who will pay, who will receive, when to administer?

Saslow D, Wheeler CM.

Ethn Dis. 2007 Spring;17(2 Suppl 2):S2-8-13.

PMID:
17684807
9.
10.

[Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].

Bégué P, Henrion R, Blanc B, Girard M, Sancho-Garnier H.

Bull Acad Natl Med. 2007 Dec;191(9):1805-16; discussion 1816-7. French.

PMID:
18663976
11.

A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005.

Calloway C, Jorgensen CM, Saraiya M, Tsui J.

J Womens Health (Larchmt). 2006 Sep;15(7):803-9. Review.

PMID:
16999634
12.

[Vaccination against cervical cancer and diseases caused by Human Papillomavirus].

Bornstein J, Tuma R, Zarfati D, Ophir E.

Harefuah. 2007 Oct;146(10):764-9, 814. Review. Hebrew.

PMID:
17990391
13.

Update on vaccination against human papillomavirus (HPV).

Weber CJ.

Urol Nurs. 2007 Aug;27(4):320-1.

PMID:
17877102
14.

Human papillomavirus disease and vaccines.

Hutchinson DJ, Klein KC.

Am J Health Syst Pharm. 2008 Nov 15;65(22):2105-12. doi: 10.2146/ajhp070627. Review.

PMID:
18997137
15.

Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.

Harper DM.

Public Health Genomics. 2009;12(5-6):319-30. doi: 10.1159/000214922. Epub 2009 Aug 11. Review.

PMID:
19684444
16.

Initial lessons learned in HPV vaccination.

Herzog TJ, Huh WK, Downs LS, Smith JS, Monk BJ.

Gynecol Oncol. 2008 May;109(2 Suppl):S4-11. doi: 10.1016/j.ygyno.2008.01.018. Review.

PMID:
18482557
17.

Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.

Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW.

Vaccine. 2008 Aug 19;26 Suppl 12:M80-8. doi: 10.1016/j.vaccine.2008.05.041.

PMID:
18945417
18.

Human papillomavirus vaccine: a paradigm shift for pediatricians.

Jenson HB.

Curr Opin Pediatr. 2009 Feb;21(1):112-21. doi: 10.1097/MOP.0b013e3283207f93. Review.

PMID:
19242247
19.

Human papillomavirus vaccine legislation in Kentucky: a policy analysis.

Dekker RL.

Policy Polit Nurs Pract. 2008 Feb;9(1):40-9. doi: 10.1177/1527154408317851. Review.

PMID:
18492941
20.

Planning for the HPV vaccine and its impact on cervical cancer prevention.

Bailey J, Cymet TC.

Compr Ther. 2006 Summer;32(2):102-5.

PMID:
16845153

Supplemental Content

Support Center